Final Verdict: 7 Clinical Facts Ozempic is not licensed for weight loss in the UK Wegovy is the licensed semaglutide weight management product Mounjaro and Wegovy are different drugs tirzepatide (dual GLP-1/GIP) vs semaglutide (GLP-1 only) In the SURMOUNT-5 head-to-head trial, Mounjaro produced 20.2% vs Wegovys 13.7% average weight loss Wegovy is approximately 75/month cheaper at Slinic maintenance doses important for cost-sensitive patients Wegovy has the NICE cardiovascular indication (April 2026) Mounjaro does not yet have this label Wegovy now has a licensed oral version (MHRA June 2026) Mounjaro does not yet have an oral equivalent Neither Ozempic off-label nor compounded alternatives are appropriate when licensed products are readily available from a GPhC-registered UK pharmacy Slinic prescribes Mounjaro and Wegovy both correctly licensed, both from Eli Lilly and Novo Nordisk authorised supply chains, both reviewed by a registered UK prescriber

Early research has suggested that GLP-1s may also reduce cravings for other addictive substances, like cocaine
The additional cost of adding TB-500 often proves worthwhile when faster, more complete healing matters
Poor dietary intake of B12-rich foods, such as meat, fish, and dairy products, is one of the most common causes of vitamin B12 deficiency
10.1210/en.2009-1197 192
That could push Lilly and Novo to compete even more aggressively on price to preserve access, or expand direct-to-employer agreements that can secure lower prices for covered drugs than what the PBM model dictates